Price: R3,199 (incl. VAT)
Strength: 5mg/0.6ml (2.4ml pen) – 20mg total
Approx. duration: 4 doses (4 weeks at 5mg/week)
What it is
Tirzepatide is a dual-action peptide that activates both GLP-1 and GIP receptors, giving it powerful effects on appetite, insulin sensitivity and weight loss. The 5mg strength is typically used as an initial or moderate dose, delivering strong appetite control and improved post-meal glucose handling with once-weekly injections. It’s an excellent choice for clients who need more metabolic support than semaglutide alone, or who want the latest dual-agonist technology for weight management.
Used for
- Weightloss clients needing more robust effects than standard GLP-1
- Insulin resistance and metabolic syndrome under medical supervision
- Reducing visceral/central fat and waist circumference
- Breaking plateaus after previous weight-loss attempts
- Early to midrange tirzepatide protocols (starter/stepup dose)
Price: R4,999 (incl. VAT)
Strength: 10mg/0.6ml (2.4ml pen) – 40mg total
Approx. duration: 8 weeks at 5mg or 4 weeks at 10mg
What it is
The 10mg tirzepatide pen is designed for higher-dose, advanced dual-agonist protocols after a client has already titrated and tolerated lower doses. By strongly activating both GLP-1 and GIP pathways, it provides intense appetite suppression, improved insulin sensitivity and powerful fat-loss support in appropriate candidates. This option is best suited to high-risk or severely overweight clients in structured medical weight-management programmes.
Used for
- Advanced tirzepatide protocols at higher maintenance doses
- Severe obesity and high cardiometabolic risk profiles
- Clients needing stronger appetite and glucose control after GLP-1s
- Long-term bodyweight and metabolic transformation plans
- Consolidating and maintaining large weight-loss achievements
At mobivIVe, doctor-reviewed compounded tirzepatide starts from R3,199 per prefilled pen, with a higher-strength 10mg pen also available. A telephone or virtual doctor consultation is required for all GLP-1 medicines before a script can be issued.
Yes. Tirzepatide is a prescription medicine and cannot be sold without a consultation. You complete a short medical questionnaire and then have a telephone or virtual consultation with our registered doctor, who issues a script if it is safe and suitable for you.
Tirzepatide works on two hormones (GLP-1 and GIP) rather than one, and in clinical use it tends to produce greater weight loss than semaglutide for many people. Which is right for you depends on your health, goals and tolerance, which is exactly what your doctor consultation determines.
Yes. Once your script is approved, your prefilled tirzepatide pen is couriered discreetly anywhere in South Africa.
Both contain the same active molecule (tirzepatide). Mounjaro is the branded, imported product; compounded tirzepatide is produced locally as a more cost-effective option, dosed to the same clinical effect on your script.